Indication-specific dosing for Mexican damiana, turnera aphrodisiaca, turnera diffusa (damiana), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.

Sections

Sections Damiana
Suggested Dosing
Suggested Uses
Interactions
Adverse Effects
Warnings
Pregnancy
Pharmacology

Suggested Dosing

No typical dosage recommendations

Classical dosage of the leaf was 2 g

Suggested Uses

headache, bedwetting, depression, nervous dyspepsia, atonic constipation, for prophylaxis and treatment of sexual disturbances, strengthening and stimulation during exertion, boosting and maintaining mental and physical capacity, and as an aphrodisiac

Efficacy

Insufficient reliable information to rate efficacy

Interaction Checker

Enter a drug name and Damiana

No Results

No Interactions Found

Interactions Found

Contraindicated

Serious - Use Alternative

Significant - Monitor Closely

Minor

All Interactions Sort By:

Contraindicated (0)

Serious - Use Alternative (0)

Monitor Closely (0)

Minor (23)

acarbose
damiana decreases effects of acarbose by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
chlorpropamide
damiana decreases effects of chlorpropamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
glimepiride
damiana decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
glipizide
damiana decreases effects of glipizide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
glyburide
damiana decreases effects of glyburide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin aspart
damiana decreases effects of insulin aspart by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin detemir
damiana decreases effects of insulin detemir by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin glargine
damiana decreases effects of insulin glargine by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin glulisine
damiana decreases effects of insulin glulisine by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin lispro
damiana decreases effects of insulin lispro by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin NPH
damiana decreases effects of insulin NPH by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin regular human
damiana decreases effects of insulin regular human by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
metformin
damiana decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
miglitol
damiana decreases effects of miglitol by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
nateglinide
damiana decreases effects of nateglinide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
pioglitazone
damiana decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
repaglinide
damiana decreases effects of repaglinide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
rosiglitazone
damiana decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
saxagliptin
damiana decreases effects of saxagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
sitagliptin
damiana decreases effects of sitagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
tolazamide
damiana decreases effects of tolazamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
tolbutamide
damiana decreases effects of tolbutamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
vildagliptin
damiana decreases effects of vildagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

acarbose
Minor (1)damiana decreases effects of acarbose by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
chlorpropamide
Minor (1)damiana decreases effects of chlorpropamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
glimepiride
Minor (1)damiana decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
glipizide
Minor (1)damiana decreases effects of glipizide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
glyburide
Minor (1)damiana decreases effects of glyburide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin aspart
Minor (1)damiana decreases effects of insulin aspart by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin detemir
Minor (1)damiana decreases effects of insulin detemir by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin glargine
Minor (1)damiana decreases effects of insulin glargine by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin glulisine
Minor (1)damiana decreases effects of insulin glulisine by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin lispro
Minor (1)damiana decreases effects of insulin lispro by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin NPH
Minor (1)damiana decreases effects of insulin NPH by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
insulin regular human
Minor (1)damiana decreases effects of insulin regular human by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
metformin
Minor (1)damiana decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
miglitol
Minor (1)damiana decreases effects of miglitol by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
nateglinide
Minor (1)damiana decreases effects of nateglinide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
pioglitazone
Minor (1)damiana decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
repaglinide
Minor (1)damiana decreases effects of repaglinide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
rosiglitazone
Minor (1)damiana decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
saxagliptin
Minor (1)damiana decreases effects of saxagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
sitagliptin
Minor (1)damiana decreases effects of sitagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
tolazamide
Minor (1)damiana decreases effects of tolazamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
tolbutamide
Minor (1)damiana decreases effects of tolbutamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
vildagliptin
Minor (1)damiana decreases effects of vildagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

Adverse Effects

None reported

Contraindications

None reported

Cautions

Excessive doses may cause insomnia & headache

Pregnancy & Lactation

Pregnancy Category: no harmful effects known

Lactation: no harmful effects known

Pregnancy Categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

Pharmacology

Metabolism: N/A

Excretion: N/A

Mechanism of Action

Reportedly has stimulant, antidepressant, thymoleptic, testosteromimetic, euphoric & nervous restorative properties

Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.

[CLOSE WINDOW]